c-Myc
Os inibidores de c-Myc têm como alvo a proteína c-Myc, um fator de transcrição que desempenha um papel crucial no crescimento celular, proliferação e apoptose. c-Myc regula a expressão de numerosos genes envolvidos no ciclo celular e é frequentemente superexpresso em vários tipos de câncer, levando a uma proliferação celular descontrolada e ao crescimento tumoral. Inibir o c-Myc pode interromper esses processos, induzindo a parada do ciclo celular e a apoptose em células cancerígenas. Os inibidores de c-Myc são ferramentas importantes na pesquisa do câncer e no desenvolvimento terapêutico. Na CymitQuimica, oferecemos uma ampla gama de inibidores de c-Myc de alta qualidade para apoiar sua pesquisa em oncologia, regulação do ciclo celular e controle transcricional.
Produtos da "c-Myc"
Ordenar por
KSI-3716
CAS:KSI-3716 is a c-Myc inhibitor, a bladder chemotherapy agent that blocks the formation of complexes between c-MYC/MAX and target gene promoters.Fórmula:C17H11BrCl2N2O2Pureza:98.94%Cor e Forma:SolidPeso molecular:426.09BRD4 Inhibitor-40
CAS:BRD4 Inhibitor-40 (Compound 23) functions as an inhibitor of BRD, effectively targeting BRD4-BD1, BRD4-BD2, BRD2-BD1, and BRD2-BD2, with IC50 values of 16.1, 142.18, 29.35, and 302.35 nM, respectively. It modulates the expression of c-Myc and p21, induces cell cycle arrest in the G1 phase, and inhibits Pkd1-deficient (PN) renal cystic epithelial cells. Additionally, it prevents renal cyst formation in both Madin-Darby canine kidney and embryonic kidney cyst models, and demonstrates renal cyst inhibition activity in mouse models.Fórmula:C27H32N8OCor e Forma:SolidPeso molecular:484.596β-catenin-IN-8
CAS:β-catenin-IN-8 (Compound 25) is an inhibitor of β-catenin. It effectively lowers the levels of both β-catenin and c-Myc proteins and suppresses Wnt target genes (Fgf20 and Sall4). Additionally, β-catenin-IN-8 exhibits anticancer activity against colorectal cancer and possesses metabolic stability.Fórmula:C15H12ClN3O2SCor e Forma:SolidPeso molecular:333.79NY2267
CAS:NY2267 (Acetic acid, 2-[[6-[2-(cyclohexylamino)-1-[[(4-methoxyphenyl)methyl](2-pyridinylcarbonyl)amino]-2-oxoethyl]-2-naphthalenyl]oxy]-, 1,1-dimethylethylFórmula:C38H43N3O6Pureza:99.16% - 99.27%Cor e Forma:SolidPeso molecular:637.76Ref: TM-T9093
1mg87,00€5mg187,00€10mg298,00€25mg525,00€50mg747,00€100mg1.017,00€1mL*10mM (DMSO)264,00€Agrimol B
CAS:1. Agrimol B is a main active ingredient isolated from Agrimonia pilosa Ledeb.Fórmula:C37H46O12Pureza:99.06% - ≥95%Cor e Forma:SolidPeso molecular:682.7510058-F4
CAS:10058-F4 inhibits c-Myc-Max, blocking c-Myc target gene activation, causing cell-cycle arrest & apoptosis.Fórmula:C12H11NOS2Pureza:98% - 99.82%Cor e Forma:SolidPeso molecular:249.35WBC100
CAS:WBC100 (14-D-Valine-TPL) is a potent, selective, and orally active c-Myc glue degrader that targets the ubiquitin E3 ligase CHIP-mediated 26S proteasome pathwayFórmula:C25H33NO7Pureza:98%Cor e Forma:SolidPeso molecular:459.53Lusianthridin
CAS:Lusianthridin is a natural product from Dendrobium venustum.Fórmula:C15H14O3Pureza:99.11% - 99.11%Cor e Forma:SolidPeso molecular:242.272-5A-dependent Rnase Protein, Human, Recombinant (Myc)
2-5A-dependent Rnase Protein, Human, Recombinant (Myc) is expressed in E.Cor e Forma:Lyophilized PowderPeso molecular:85.1 kDa (predicted)MYC-RIBOTAC
MYC-RIBOTAC, a ribonuclease-targeting chimera (RIBOTAC) specific to the MYC internal ribosome entry site (IRES), comprises an MYC mRNA-binding element tetheredFórmula:C55H58N10O11SPureza:98%Cor e Forma:SolidPeso molecular:1067.17Saxagliptin hydrate
CAS:Saxagliptin hydrate (Onglyza hydrate) is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).Fórmula:C18H25N3O2·H2OPureza:99.52%Cor e Forma:SolidPeso molecular:333.43APTO-253
CAS:APTO-253 (LOR-253) inhibits c-Myc expression, stabilizes G-quadruplex DNA, and induces cell cycle arrest and apoptosis in acute myeloid leukemia cells.Fórmula:C22H14FN5Pureza:98.73%Cor e Forma:SolidPeso molecular:367.38Ref: TM-T10352
1mg43,00€2mg55,00€5mg80,00€10mg101,00€25mg180,00€50mg284,00€100mg411,00€200mg597,00€1mL*10mM (DMSO)88,00€c-Myc inhibitor 12
Compound 67h, also known as c-Myc inhibitor 12, is a potent inhibitor of c-Myc, exhibiting a pEC50 value of 6.4 [1].Fórmula:C22H24N6OPureza:98%Cor e Forma:SolidPeso molecular:388.4710074-A4
CAS:10074-A4 is a c-Myc binding compound that associates with c-Myc370-409 and behaves like a “ligand cloud” around a “protein cloud”, with distinct features fromFórmula:C18H14Cl2N2O3SPureza:98.01%Cor e Forma:SolidPeso molecular:409.29Ref: TM-T9628
1mg71,00€5mg135,00€10mg197,00€25mg335,00€50mg480,00€100mg662,00€200mg892,00€1mL*10mM (DMSO)156,00€PARL Protein, Human, Recombinant (Myc)
Required for the control of apoptosis during postnatal growth.Cor e Forma:Lyophilized PowderPeso molecular:37.8 kDa (predicted)MYCi975
CAS:MYCi975 (NUCC-0200975) is an orally active inhibitor of MYC.Fórmula:C25H16Cl2F6N2O2Pureza:99.3% - 99.58%Cor e Forma:SolidPeso molecular:561.310074-G5
CAS:10074-G5 is an inhibitor of c-Myc-Max dimerization.Fórmula:C18H12N4O3Pureza:97.22% - 99.67%Cor e Forma:SolidPeso molecular:332.31Ref: TM-T3686
2mg42,00€5mg63,00€10mg88,00€25mg142,00€50mg225,00€100mg396,00€200mg565,00€500mg900,00€1mL*10mM (DMSO)69,00€Artemisitene
CAS:Artemisitene, an oxidized antimalarial derivative of Artemisinin, stems from precursors like Artemisinin B and Artemisinic acid.Fórmula:C15H20O5Pureza:99.58%Cor e Forma:SolidPeso molecular:280.32Ref: TM-T21065
1mg95,00€5mg187,00€10mg329,00€25mg560,00€50mg800,00€100mg1.103,00€1mL*10mM (DMSO)281,00€Nicotinamide N-oxide
CAS:Nicotinamide N-oxide, a metabolite of nicotinamide and precursor to NAD+, is reduced by liver enzyme xanthine oxidase.Fórmula:C6H6N2O2Pureza:99.61% - 99.9%Cor e Forma:SolidPeso molecular:138.12Idarubicin hydrochloride
CAS:Idarubicin hydrochloride (Zavedos), a hydrochloride salt form of Idarubicin, is a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells ( IC50: 3.3 ng/mL).Fórmula:C26H27NO9·HClPureza:100% - 99.93%Cor e Forma:SolidPeso molecular:533.95
